[1] Gershwin ME,Selmi C,Worman HJ,et al.Risk factors and comorbidities in primary biliary cirrhosis：a controlled interview based study of 1032 patient.Hepatology,2005,42（5）：1194-1202.
[2] Ala A,Stanca CM. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology,2006,43（3）：525-531.
[3] Selmi C,Mayo MJ,Bach N,et al.Primary biliary cirrhosis in monozygotic and dizygotic twins：genetics,epigenetics,and environment.Gastroenterology,2004,127：485-492.
[4] Lindor KD,Gershwin ME,Poupon R,et al.Primary biliary cirrhosis.Hepatology,2009,50：291-308.
[5] Geier MR,Geier DA.A case-series of adverse events,positive rechallenge of symptoms,and events in identical twins following hepatitis B vaccination：analysis of vaccine adverse event reporting system（VAERS） database and literature review. Clin Exp Rheumatol,2004,22（6）：749-755.
[6] Leung PS,Park O,Tsuneyama K,et al.Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization.Immunology,2007,179：2651-2657.
[7] Zein CO,Angulo P,Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis. Clin Gastroenterol Hepatol,2003,1：89-95.
[8] Corpechot C,ElNaggar A,Poujol-Robert A,et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology,2006,43：1118-1124.
[9] Prince MI,Chetwynd A,Craig WL,et al. Asymptomatic primary biliary cirrhosis：clinical features,prognosis,and symptom progression in a large population based cohort.Gut,2004,53：865-870.
[10] Forton DM,Patel N,Prince M,et al. Fatigue and primary biliary cirrhosis：association of globus pallidus magnetization transfer ratio measurements with fatigue severity and blood manganese levels. Gut,2004,3：587-592.
[11] Newton JL,Jones DE. Modanil is effective treatment for excessive daytime somnolence and fatigue in primary biliary cirrhosis. Hepatology,2006,44：628A.
[12] Poupon RE,Chretien Y,Chazouilleres O,et al.Quality of life in patients with primary biliary cirrhosis. Hepatology,2004,40：489-494.
[13] Pares A,Caballeria L,Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid.Gastroenterology,2006,130：715-720.
[14] Corpechot C,Carrat F,Bahr A,et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.Gastroenterology,2005,128：297-203.
[15] Boberg KM,Wisloff T,Kjollesdal KS,et al. Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.Aliment Pharmacol Ther,2013,38（7）：794-803. |
